Previous studies report that IGFBP5 influences pancreatic cancer cell growth and survival via the MAPK or PI3K pathway, and enhances prostate cancer growth through activation of the PI3K pathway [25, 26]. This evidence concerns the gene IGFBP5 and pancreatic neoplasm.